Odyssey Therapeutics

(NASDAQ) ODTX

Current Price$17.15

Market Cap$807.62M

Since IPO (2026)+4%

5 YearN/A

1 YearN/A

1 Month+4%

Odyssey Therapeutics Financials at a Glance

Market Cap

$807.62M

Revenue (TTM)

$1.76

Net Income (TTM)

-$35.93

EPS (TTM)

$0.00

P/E Ratio

0.00

Dividend

$0.00

Beta (Volatility)

-2.58 (Low)

Dividend

$0.00

Beta (Volatility)

-2.58 (Low)

Price

$17.15

Volume

269,275.218

Open

$17.25

Price

$17.15

Volume

269,275.218

Open

$17.25

Previous Close

$17.09

Daily Range

$16.93 - $17.55

52-Week Range

$15.35 - $20.30

Estimated Earnings Date

Sep 2, 2026

Dividend

$0.00

Beta (Volatility)

-2.58 (Low)

Price

$17.15

Volume

269,275.218

Open

$17.25

Previous Close

$17.09

Daily Range

$16.93 - $17.55

52-Week Range

$15.35 - $20.30

Estimated Earnings Date

Sep 2, 2026

ODTX News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Odyssey Therapeutics

Industry

Biotechnology

Sector

Health Care

CEO

Gary D. Glick, PhD

Website

www.odysseytx.com

Headquarters

Boston, MA 02210, US

ODTX Financials

Key Financial Metrics (TTM)

Gross Margin

N/A

Operating Margin

N/A

Net Income Margin

N/A

Return on Equity

Return on Capital

N/A

Return on Assets

N/A

Earnings Yield

N/A

Dividend Yield

0.00%

Payout Ratio

N/A

Stock Overview

Market Cap

$807.62M

Shares Outstanding

47.17M

Volume

269.28K

Avg. Volume

442.21K

Financials (TTM)

Gross Profit

N/A

Operating Income

N/A

EBITDA

N/A

Operating Cash Flow

N/A

Capital Expenditure

N/A

Free Cash Flow

N/A

Cash & ST Invst.

N/A

Total Debt

N/A

Odyssey Therapeutics Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name

Q4 2024YOY CHG

Revenue

$1.76

N/A

Gross Profit

$0.46

N/A

Gross Margin

26.32%

N/A

Market Cap

$807.62M

N/A

Market Cap/Employee

N/A

Employees

N/A

Net Income

-$35.93

N/A

EBITDA

-$35.83

N/A

Quarterly Fundamentals

Name

Q4 2024YOY CHG

Net Cash

$59.14

N/A

Accounts Receivable

N/A

Inventory

$0.00

N/A

Long Term Debt

$26.43

N/A

Short Term Debt

$4.58

N/A

Return on Assets

N/A

Return on Invested Capital

N/A

Free Cash Flow

N/A

Operating Cash Flow

N/A

Other Investments to Explore

People Also Watch

SymbolSymbol / CompanyCompanyPricePrice Chg

^GSPCS&P 500

^GSPCS&P 500$7,362.12-0.01%

^DJIDJI

^DJIDJI$50,799.09+0.00%

^IXICNASDAQ

^IXICNASDAQ$25,583.39-0.01%

BTCBitcoin

BTCBitcoin$61,689.00-0.03%

AAPLAAPL

AAPLAAPL$290.85-0.04%

AMZNAMZN

AMZNAMZN$245.28+0.00%

GOOGGOOG

GOOGGOOG$362.85+0.00%

Trending Stocks

SymbolSymbol / CompanyCompanyPricePrice Chg

NOKNokia

NOKNokia$13.85-0.05%

SQQQProShares Trust - ProShares UltraPro Short Qqq

SQQQProShares Trust - ProShares UltraPro Short Qqq$42.67+0.03%

KEELKeel Infrastructure

KEELKeel Infrastructure$5.42-0.04%

QQQInvesco QQQ Trust

QQQInvesco QQQ Trust$707.83-0.01%

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares$13.02-0.06%

AURAurora Innovation

AURAurora Innovation$6.14-0.02%

NVDANvidia

NVDANvidia$207.74-0.00%

Questions About ODTX

What is the current price of Odyssey Therapeutics?

Odyssey Therapeutics is trading at $17.09 per share.

What is the 52-week range for Odyssey Therapeutics?

Over the past 52 weeks, Odyssey Therapeutics has traded between $15.35 and $20.30.

How much debt does Odyssey Therapeutics have?

As of the most recent reporting period, Odyssey Therapeutics reported total debt of $31.01M.

How much cash does Odyssey Therapeutics have on hand?

Odyssey Therapeutics reported $59.14M in cash and cash equivalents in its most recent financial results.

What is Odyssey Therapeutics’s dividend yield?

Odyssey Therapeutics does not currently have a dividend yield.

Odyssey Therapeutics

Odyssey Therapeutics Financials at a Glance

ODTX News

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

About Odyssey Therapeutics

ODTX Financials

Key Financial Metrics (TTM)

Stock Overview

Financials (TTM)

Odyssey Therapeutics Performance Analysis

Revenue Growth Rate

Earnings Per Share Growth Rate

Quarterly Performance

Quarterly Fundamentals

Other Investments to Explore

People Also Watch

Trending Stocks

Questions About ODTX

What is the current price of Odyssey Therapeutics?

What is the 52-week range for Odyssey Therapeutics?

How much debt does Odyssey Therapeutics have?

How much cash does Odyssey Therapeutics have on hand?

What is Odyssey Therapeutics’s dividend yield?

Premium Investing Services